3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase NA
1
Phase 4
1
Phase 2/3
1
Phase 1
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
11
Thoracic
7
Gastrointestinal
6
CNS
4
Sarcoma
3
Other hematologic neoplasm
3
Head & Neck
3
Gynecologic
3
Dermatologic
3
Genitourinary
2
Tumor-Agnostic
1
Myeloid
1
Lymphoid
1
Conditions
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Peripheral Nervous System Diseases
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Interventions
Paclitaxel
150
Carboplatin
110
Cisplatin
94
Bevacizumab
42
Topotecan
39
Gemcitabine
38
liposomal doxorubicin
34
Radiotherapy
29
Doxorubicin
27
Brachytherapy
26
Taxes
24
pembrolizumab
20
olaparib
20
Drug Therapy
20
Hyperthermic Intraperitoneal Chemotherapy
16
Chemotherapy, Adjuvant
16
human papillomavirus vaccine, L1 type 16, 18
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
14
Docetaxel
13
Neoadjuvant Therapy
12
Platinum
10
niraparib
9
Radiation
9
1,2-diaminocyclohexaneplatinum II citrate
9
Vaccines, Synthetic
8
Surgical Procedures, Operative
8
atezolizumab
7
Specimen Handling
7
Papillomavirus Vaccines
7
Letrozole
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Sodium Chloride
×
Gynecologic
×
Clear all
NCT06079671
2026-05-27
eVOLVECervical
AstraZeneca
Phase 3
Recruiting
800 enrolled
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled